Baxter International | BAX - Despesas Operacionais

Preço das Ações
17.08
Mudança Diária
-0.32 -1.84%
Mensal
-17.65%
Anual
-50.99%
Q1 Previsão
16.87




Despesas Operacionais Alterar Data
Abbott USD 9.21B 17M 2025-12
AngioDynamics USD 81.98M 1.96M 2025-02
Artivion USD 111.2M 9.45M 2025-12
AtriCure USD 138.01M 3.95M 2025-12
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.2B 71.3M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Halozyme Therapeutics USD 211.07M 74.73M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Inogen USD 49.14M 665K 2024-09
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
J&J USD 18.97B 2.38B 2025-12
Laboratory Of America USD 3.13B 32.4M 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Quest Diagnostics USD 2.42B 4.84B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12